Positive PET in a Patient With Esophageal Leiomyoma.

Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease.

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.